Clinical Trial Update: StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis [Phase 4]

View source ↗

Summary

This clinical trial update discusses a Phase 4 study evaluating strategies for zoledronic acid after discontinuation of denosumab in postmenopausal osteoporosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Zoledronic acid (Reclast) (zoledronic acid)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Postmenopausal Osteoporosis | Phase 4 | Status: RECRUITING